These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 38420922)

  • 1. α-Synuclein: Multiple pathogenic roles in trafficking and proteostasis pathways in Parkinson's disease.
    Zalon AJ; Quiriconi DJ; Pitcairn C; Mazzulli JR
    Neuroscientist; 2024 Oct; 30(5):612-635. PubMed ID: 38420922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
    Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
    J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking.
    Stojkovska I; Wani WY; Zunke F; Belur NR; Pavlenko EA; Mwenda N; Sharma K; Francelle L; Mazzulli JR
    Neuron; 2022 Feb; 110(3):436-451.e11. PubMed ID: 34793693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Autophagic-Lysosomal Fusion in Parkinson's Patient Midbrain Neurons Occurs through Loss of ykt6 and Is Rescued by Farnesyltransferase Inhibition.
    Pitcairn C; Murata N; Zalon AJ; Stojkovska I; Mazzulli JR
    J Neurosci; 2023 Apr; 43(14):2615-2629. PubMed ID: 36788031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson's disease.
    Yang Y; Song JJ; Choi YR; Kim SH; Seok MJ; Wulansari N; Darsono WHW; Kwon OC; Chang MY; Park SM; Lee SH
    Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2110746119. PubMed ID: 35858361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Zebrafish Model to Measure Neuronal α-Synuclein Clearance In Vivo.
    Lopez A; Gorb A; Palha N; Fleming A; Rubinsztein DC
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein in Parkinson's disease: causal or bystander?
    Riederer P; Berg D; Casadei N; Cheng F; Classen J; Dresel C; Jost W; Krüger R; Müller T; Reichmann H; Rieß O; Storch A; Strobel S; van Eimeren T; Völker HU; Winkler J; Winklhofer KF; Wüllner U; Zunke F; Monoranu CM
    J Neural Transm (Vienna); 2019 Jul; 126(7):815-840. PubMed ID: 31240402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models.
    Mazzulli JR; Zunke F; Isacson O; Studer L; Krainc D
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1931-6. PubMed ID: 26839413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Lysosomal Exocytosis Induced by Lysosomal Ca
    Tsunemi T; Perez-Rosello T; Ishiguro Y; Yoroisaka A; Jeon S; Hamada K; Rammonhan M; Wong YC; Xie Z; Akamatsu W; Mazzulli JR; Surmeier DJ; Hattori N; Krainc D
    J Neurosci; 2019 Jul; 39(29):5760-5772. PubMed ID: 31097622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.
    Benskey MJ; Perez RG; Manfredsson FP
    J Neurochem; 2016 May; 137(3):331-59. PubMed ID: 26852372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis.
    Gitler AD; Bevis BJ; Shorter J; Strathearn KE; Hamamichi S; Su LJ; Caldwell KA; Caldwell GA; Rochet JC; McCaffery JM; Barlowe C; Lindquist S
    Proc Natl Acad Sci U S A; 2008 Jan; 105(1):145-50. PubMed ID: 18162536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research Progress of α-Synuclein Aggregation Inhibitors for Potential Parkinson's Disease Treatment.
    Kalsoom I; Wang Y; Li B; Wen H
    Mini Rev Med Chem; 2023; 23(20):1959-1974. PubMed ID: 37198991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy.
    Siwecka N; Saramowicz K; Galita G; Rozpędek-Kamińska W; Majsterek I
    Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models.
    Su LJ; Auluck PK; Outeiro TF; Yeger-Lotem E; Kritzer JA; Tardiff DF; Strathearn KE; Liu F; Cao S; Hamamichi S; Hill KJ; Caldwell KA; Bell GW; Fraenkel E; Cooper AA; Caldwell GA; McCaffery JM; Rochet JC; Lindquist S
    Dis Model Mech; 2010; 3(3-4):194-208. PubMed ID: 20038714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson's Disease.
    Ren H; Zhai W; Lu X; Wang G
    Front Aging Neurosci; 2021; 13():691881. PubMed ID: 34168552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease.
    Bridi JC; Hirth F
    Front Neurosci; 2018; 12():80. PubMed ID: 29515354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapeutic approaches to target alpha-synuclein in Parkinson's disease: The role of immunotherapy.
    Fernández-Valle T; Gabilondo I; Gómez-Esteban JC
    Int Rev Neurobiol; 2019; 146():281-295. PubMed ID: 31349931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage.
    Franco R; Rivas-Santisteban R; Navarro G; Pinna A; Reyes-Resina I
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson's disease.
    Brazdis RM; Alecu JE; Marsch D; Dahms A; Simmnacher K; Lörentz S; Brendler A; Schneider Y; Marxreiter F; Roybon L; Winner B; Xiang W; Prots I
    Hum Mol Genet; 2020 May; 29(7):1180-1191. PubMed ID: 32160287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione
    Jewett M; Dickson E; Brolin K; Negrini M; Jimenez-Ferrer I; Swanberg M
    Front Neurol; 2018; 9():222. PubMed ID: 29681884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.